PSME1 and melanoma: Related with this, one of the significantly underexpressed proteins was PSME1 (proteasome activator complex subunit 1), which is a regulator of proteasome activity [23], suggesting that HS treatment inhibits protein degradation in melanoma cells and, in turn, can contribute to modify protein homeostasis.